Gastrointestinal Cancer News

The NIH has awarded a $1.85 million grant to researchers from Case Western Reserve University School of Medicine to better learn how non-coding genes work in the progression of colorectal cancer, according to a press release.

The FDA awarded more than $18 million in grants over the next 4 years to fund clinical trials of medical products intended to treat patients with rare diseases.

Two colonoscopy techniques designed to provide a better view in the right side of the colon both improved adenoma detection over standard colonoscopy withdrawal, according to research published in Gastrointestinal Endoscopy.

Two colonoscopy techniques designed to provide a better view in the right side of the colon both improved adenoma detection over standard colonoscopy withdrawal, according to research published in Gastrointestinal Endoscopy.

Individuals with cancer appeared 10 times less likely than the general population to die as a result of opioid use, according to retrospective study results presented at ASCO Quality Care Symposium.

The implementation of an organized screening program of annual fecal immunochemical tests combined with colonoscopy demonstrated a significant, and rapid, increase of colorectal cancer screening participation, according to results of a dynamic cohort of health plan members at an institution.

Valsartan products that were contaminated with N-nitrosodimethylamine, an impurity that has been classified as a probable human carcinogen that led to recalls of several drug products by the FDA, did not markedly increase the short-term overall risk for cancer, according to a study published in The BMJ.

At the conventional fecal immunochemical test positivity threshold, programmatic sensitivity for detection of colorectal cancer decreased as age increased and was higher in men than women, according to data published in Annals of Internal Medicine.

The anti-inflammatory and anti-neoplastic agent taurolidine significantly decreased IL-6 levels in patients undergoing colon cancer surgery, potentially improving outcomes, according to results of a randomized, placebo-controlled controlled trial.

Jordan M. Winter, MD, has been appointed chief of the division of surgical oncology at University Hospitals Cleveland Medical Center.